Allogeneic ABCB5+ Mesenchymal Stem Cells for Treatment-Refractory Chronic Venous Ulcers: A Phase I/IIa Clinical Trial

Andreas Kerstan, Kathrin Dieter, Elke Niebergall-Roth, Ann-Kathrin Dachtler, Korinna Kraft, Markus Stücker, Georg Daeschlein, Michael Jünger, Tobias Görge, Ulrich Meyer-Pannwitt, Cornelia Erfurt-Berge, Charlotte von Engelhardt, Andreas Klare, Christiane Pfeiffer, Jasmina Esterlechner, Hannes M. Schröder, Martin Gasser, Ana M. Waaga-Gasser, Matthias Goebeler, Seda Ballikaya, Samar Sadeghi, George F. Murphy, Dennis P. Orgill, Natasha Y. Frank, Christoph Ganss, Karin Scharffetter-Kochanek, Markus H. Frank, Mark A. Kluth

Open source

DOI: 10.1016/j.xjidi.2021.100067
Published: 2022-01
Container: JID Innovations
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.xjidi.2021.100067,
  title = {Allogeneic ABCB5+ Mesenchymal Stem Cells for Treatment-Refractory Chronic Venous Ulcers: A Phase I/IIa Clinical Trial},
  author = {Andreas Kerstan and Kathrin Dieter and Elke Niebergall-Roth and Ann-Kathrin Dachtler and Korinna Kraft and Markus Stücker and Georg Daeschlein and Michael Jünger and Tobias Görge and Ulrich Meyer-Pannwitt and Cornelia Erfurt-Berge and Charlotte von Engelhardt and Andreas Klare and Christiane Pfeiffer and Jasmina Esterlechner and Hannes M. Schröder and Martin Gasser and Ana M. Waaga-Gasser and Matthias Goebeler and Seda Ballikaya and Samar Sadeghi and George F. Murphy and Dennis P. Orgill and Natasha Y. Frank and Christoph Ganss and Karin Scharffetter-Kochanek and Markus H. Frank and Mark A. Kluth},
  year = {2022},
  journal = {JID Innovations},
  doi = {10.1016/j.xjidi.2021.100067},
  url = {https://doi.org/10.1016/j.xjidi.2021.100067}
}

RIS

TY  - JOUR
TI  - Allogeneic ABCB5+ Mesenchymal Stem Cells for Treatment-Refractory Chronic Venous Ulcers: A Phase I/IIa Clinical Trial
AU  - Andreas Kerstan
AU  - Kathrin Dieter
AU  - Elke Niebergall-Roth
AU  - Ann-Kathrin Dachtler
AU  - Korinna Kraft
AU  - Markus Stücker
AU  - Georg Daeschlein
AU  - Michael Jünger
AU  - Tobias Görge
AU  - Ulrich Meyer-Pannwitt
AU  - Cornelia Erfurt-Berge
AU  - Charlotte von Engelhardt
AU  - Andreas Klare
AU  - Christiane Pfeiffer
AU  - Jasmina Esterlechner
AU  - Hannes M. Schröder
AU  - Martin Gasser
AU  - Ana M. Waaga-Gasser
AU  - Matthias Goebeler
AU  - Seda Ballikaya
AU  - Samar Sadeghi
AU  - George F. Murphy
AU  - Dennis P. Orgill
AU  - Natasha Y. Frank
AU  - Christoph Ganss
AU  - Karin Scharffetter-Kochanek
AU  - Markus H. Frank
AU  - Mark A. Kluth
PY  - 2022
JO  - JID Innovations
DO  - 10.1016/j.xjidi.2021.100067
UR  - https://doi.org/10.1016/j.xjidi.2021.100067
ER  -

APA

Kerstan, A., Dieter, K., Niebergall-Roth, E., Dachtler, A., Kraft, K., Stücker, M., Daeschlein, G., Jünger, M., Görge, T., Meyer-Pannwitt, U., Erfurt-Berge, C., Engelhardt, C. V., Klare, A., Pfeiffer, C., Esterlechner, J., Schröder, H. M., Gasser, M., Waaga-Gasser, A. M., Goebeler, M., Ballikaya, S., Sadeghi, S., Murphy, G. F., Orgill, D. P., Frank, N. Y., Ganss, C., Scharffetter-Kochanek, K., Frank, M. H., & Kluth, M. A. (2022). Allogeneic ABCB5+ Mesenchymal Stem Cells for Treatment-Refractory Chronic Venous Ulcers: A Phase I/IIa Clinical Trial. JID Innovations. https://doi.org/10.1016/j.xjidi.2021.100067

Source records

crossref · retrieved 2026-09-25T20:03:52.401Z